Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

IMP-Researcher Johannes Zuber wins German Cancer Prize

25.02.2016

Johannes Zuber, group leader at the Research Institute of Molecular Pathology (IMP) in Vienna, receives the German Cancer Prize 2016 in the category of experimental cancer research. This was announced today at the opening ceremony of the German Cancer Congress in Berlin.

The German Cancer Prize (Deutscher Krebspreis) is one of the most prestigious scientific awards in the German speaking world and annually honours researchers for groundbreaking discoveries in the field of oncology.


IMP Group Leader Johannes Zuber

Copyright: IMP/Fischer

This year's award acknowledges the achievements of Johannes Zuber, whose contributions have shaped the field of functional cancer genetics. Together with his team at the IMP, the physician scientist uses innovative genetic approaches to identify and study genes that are required for the survival of cancer cells and serve as candidate targets for the development of new cancer therapies.

Through developing and applying optimised RNAi-screening methods, Zuber discovered the gene BRD4 as a genetic vulnerability and candidate target for the treatment of acute myeloid leukemia (AML), an aggressive form of blood cancer.

After BRD4 inhibitors have already shown promising effects in AML and other malignancies, his research team could recently identify molecular mechanisms that render leukemia cells resistant to these agents. These insights are of great importance for the future development of BRD4 inhibitors in the clinic.

“This award is a great honour and encouragement to further expand our research in the field of functional cancer genetics”, says Johannes Zuber. He points out that new genetic tools offer fascinating opportunities for finding and probing therapeutic targets such as BRD4: “We are currently witnessing a true revolution in functional genetics, which will enable us to search for better cancer therapies in entirely new ways.”

Johannes Zuber, born 1974 in Dresden, completed his medical studies and a doctoral thesis in molecular cancer research at Berlin’s Charité Medical School in 2003. During his residency in hematology/oncology at the Charité University Hospital, leukemia became the focus of his scientific interest. In 2005, Zuber moved to the US to join Scott Lowe's lab at the renowned Cold Spring Harbor Laboratory, where he developed innovative genetic models to study targeted therapies in leukemia. In 2011, he founded his own lab at the IMP in Vienna.

The German Cancer Prize is endowed with 22,500 Euros and awarded annually by the “Deutsche Krebsgesellschaft” (German Cancer Society) and the “Deutsche Krebsstiftung” (German Cancer Foundation) for groundbreaking work in three categories: experimental research, translational research and clinical research in oncology.

The criteria are exceptional scientific quality and originality of research in the field of oncology. Former awardees include renowned scientists such as Nobel laureate Harald zur Hausen, Peter Krammer, Axel Ullrich or Walter Birchmeier. Johannes Zuber is the first recipient who is affiliated with an institution in Austria.

About the IMP
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 37 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology.

Media Contact at the IMP
Dr. Heidemarie Hurtl
IMP Communications
Research Institute of Molecular Pathology
Dr. Bohr-Gasse 7
A 1030 Vienna
hurtl@imp.ac.at
+43 (0)1 79730 3625

Weitere Informationen:

http://www.imp.ac.at/research/research-groups/zuber-group/
http://www.imp.ac.at/news/press-releases/

Dr. Heidemarie Hurtl | idw - Informationsdienst Wissenschaft

More articles from Awards Funding:

nachricht Breakthrough Prize for Kim Nasmyth
04.12.2017 | IMP - Forschungsinstitut für Molekulare Pathologie GmbH

nachricht The key to chemical transformations
29.11.2017 | Schweizerischer Nationalfonds SNF

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>